Prologium Pharmaceutical: 2025 Net Profit Down 13.62% YoY; Proposes Dividend of 2.38 Yuan per 10 Shares

2026-03-21 16:07:45

People’s Financial News, March 19 — Prolo Pharmaceutical (000739) released its 2025 annual report on March 19. Revenue was 9.784 billion yuan, down 18.62% year-over-year; net profit attributable to shareholders of the listed company was 891 million yuan, down 13.62% year-over-year; basic earnings per share were 0.7723 yuan. The company plans to distribute a cash dividend of 2.38 yuan (tax included) for every 10 shares to all shareholders.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.